Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-22T14:25:41.610Z Has data issue: false hasContentIssue false

A non-randomized pilot study to test the feasibility of treating chronic pain and opioid prescription use in rural areas with acceptance and commitment therapy (T-PACT)

Published online by Cambridge University Press:  24 March 2020

Robert L Rhyne*
Affiliation:
Department of Family and Community Medicine, Community Engagement and Research Core, Clinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Heidi Rishel Brakey
Affiliation:
Clinical and Translational Science Center, University of New Mexico Health Science Center, Albuquerque, NM, USA
Jacquie R. Halladay
Affiliation:
Department of Family Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA North Carolina Translational and Clinical Sciences (NC TraCS) Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Kathleen Mottus
Affiliation:
North Carolina Translational and Clinical Sciences (NC TraCS) Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
K. Allen Greiner
Affiliation:
Department of Family Medicine, Kansas Patients and Providers Engaged in Prevention Research (KPPEPR), University of Kansas Medical Center, Kansas City, KS, USA
Elizabeth Salt
Affiliation:
College of Nursing, University of Kentucky, Lexington, KY, USA
Orrin Myers
Affiliation:
Department of Family and Community Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Kent Sutton
Affiliation:
Cecil G. Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
Jesus Fuentes
Affiliation:
Clinical and Translational Science Center, University of New Mexico Health Science Center, Albuquerque, NM, USA
Kevin E. Vowles
Affiliation:
Centre for Improving Health-Related Quality of Life, School of Psychology, Queen’s University Belfast, Belfast, UK
*
Address for correspondence: R. L. Rhyne, MD, UNM School of Medicine, MSC 09 5040, 1 UNM, Albuquerque, NM 87131, USA. Email: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Chronic non-cancer pain (CNCP) involves one-third of the US population, and prescription opioids contribute to the opioid epidemic. The Centers for Disease Control and Prevention emphasizes maximizing non-opioid treatment, but many rural populations cannot access alternative therapies. Clinical and Translational Science Award hubs across four rural states performed a multi-site, single-arm intervention feasibility study testing methods and procedures of implementing a behavioral intervention, acceptance and commitment therapy, in primary care CNCP patients on chronic opioids. Using the CONSORT extension for feasibility studies, we describe lessons learned in recruiting/retaining participants, intervention implementation, data measurement, and multi-site procedures. Results inform a future definitive trial and potentially others conducting rural trials.

Type
Brief Report
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Association for Clinical and Translational Science 2020

Introduction

Chronic non-cancer pain (CNCP) affects approximately one-third of the US population. Opioids have been overprescribed for CNCP resulting in the current “opioid overdose crisis,” as described by the Centers for Disease Control and Prevention (CDC) [1]. Overprescribing became widespread partly as a result of actions by the pharma industry [Reference Hadland2], despite strong evidence for nonpharmacological pain treatment, and a lack of evidence that medication treatment alone optimizes function and long-term outcomes for CNCP patients [Reference Chou3,Reference Salt4]. Many rural regions of the country have been especially impacted by the opioid crisis [5].

CDC opioid-prescribing guidelines emphasize maximizing non-opioid therapy before prescribing opioids [Reference Dowell, Haegerich and Chou6]. However, poor access to healthcare services in rural areas has contributed to limited use of nonpharmacological treatments. Behavioral interventions are underutilized in CNCP management. Acceptance and commitment therapy (ACT) is a type of behavioral counselling where patients learn to focus on their present situation with CNCP, accept their condition, and find positive coping skills [Reference Vowles and Sorrell7]. ACT has been effective for chronic pain [8,Reference Vowles, Wetherell and Sorrell9] but has not been tested in rural primary care settings.

Some of the same barriers to performing research in rural areas are also associated with health disparities, namely geographic isolation, shortage of healthcare providers, poverty, transportation difficulties, and less access to healthcare [Reference Friedman10]. Also, translational research and recruitment for trials in rural clinical settings are limited by a lack of research infrastructure, awareness, education, and experience by providers, as well as competing demands on clinic personnel and workflow [Reference Kim11].

Feasibility studies are crucial for planning effectiveness trials, investigating proposed methods, and determining if trials can be performed [Reference Eldridge12]. Specific CONSORT-reporting guidelines and checklists have been extended to randomized feasibility studies, and certain principles can also be used for non-randomized pilot studies [Reference Schulz, Altman and Moher13,Reference Eldridge14]. Feasibility studies allow study teams to gauge potential hurdles in performing larger, multi-site, pragmatic randomized controlled trials (RCTs) [Reference Kristunas15].

Our research team, comprised of investigators from four Clinical and Translational Science Award (CTSA) hubs, collaborated to perform this non-randomized pilot study in rural areas of North Carolina, Kentucky, Kansas, and New Mexico among primary care patients with CNCP who were treated with prescription opioids. The aim of this study was to evaluate the feasibility of testing ACT as a behavioral intervention and evaluating the multi-site study procedures for a future RCT. Specifically, our objectives for this study focused on the following major CONSORT checklist items: single IRB, recruitment and retention of participants through practices, implementation of the ACT intervention, and collection of study data across sites.

Methods

The Rural Health Research Support Network [16] is a collaborative effort among CTSA hubs to facilitate and provide support for multi-site CTR studies in rural populations. It led to the collaboration of four CTSA hubs to design and conduct this feasibility study at the Universities of New Mexico (UNM), North Carolina, Kansas, and Kentucky. This study was approved using SMART IRB with UNM as the reviewing IRB [Reference Cobb17]. The study was registered with ClinicalTrials.gov (ID: NCT03666455). Each CTSA funded the study at $25,000 ($100,000 total).

This non-randomized pilot study tested the feasibility, methods, and procedures of implementing ACT across four sites. The implementation period for this study was January through September 2019. It is in progress as some data collection is ongoing. Each site recruited one rural primary care practice (PCP) with behavioral health support availability within or closely associated with the practice. At least one master’s level or higher behavioral health therapist per site was recruited and trained to deliver the ACT intervention. Our target sample size was 5 patients per site, or 20 totally, using the following eligibility criteria: age 21–65, diagnosis of CNCP, chronic prescription opioid use, ability to complete an extensive survey at three time points, and ability to attend all ACT therapy sessions. To allow for dropouts, our aim was to recruit seven patients from each PCP in order to retain five through all ACT sessions. Each site team oriented their PCP to the study and its methods, and relied primarily on providers for recruitment by identifying and distributing study flyers to prospective participants, which had a contact number for study personnel.

ACT is an empirically supported [Reference Vowles, Wetherell and Sorrell9], structured, eight-session behavioral therapy designed to help patients accept their CNCP and commit to positive coping skills. Co-founder KV trained therapists over eight 2-hour sessions using a treatment manual [Reference Vowles and Sorrell7] and videoconferencing platform. The training covered the concepts and theory of each session, its goals and objectives, treatment methods, and application. Sessions were audio-recorded for the purposes of clinical supervision and intervention fidelity assessment.

Patients were to complete baseline surveys including demographics and standardized measures, eight sessions of ACT, and a brief pain measure at each therapy session. Follow-up measures and semi-structured interviews were scheduled to be collected after the intervention but are not included here because they were not part of the intervention period being tested in this study. The standardized baseline measures included pain outcome measures, comorbidity behavioral health measures, and prescription opioid aberrant behavior measures. Pain measures included the Brief Pain Inventory (BPI) and its brief version, the Pain, Enjoyment of life and General Activity (PEG), both of which measure pain intensity and interference with daily function. The BPI was collected at baseline and the PEG was collected at each ACT session. Other measures included the Short Form Health Survey (SF-36), a measure of functional health and well-being; the Patient Health Questionnaire depression scale (PHQ-8); the Chronic Pain Acceptance Questionnaire – Revised, a measure of the acceptance of chronic pain; the Chronic Pain Values Inventory, a measure based on the values-based ACT treatment; the Current Opioid Misuse Measure, used to monitor pain patients on opioids regarding aberrant medication behaviors; and the Brief Adverse Childhood Events measure.

Investigators elicited feedback on study and implementation methods from research staff and PCP teams. At scheduled team videoconferences twice monthly, we discussed these issues and generated a list of key themes, best practices, and lessons learned in performing this multi-site feasibility study.

Results

Of the targeted number of 20–28 participants, we recruited 21 totally (Table 1). The majority were female, Non-Hispanic White, over 50 years of age, high school or higher educated, and in the $50,000 yearly income range. Of the 21, only four, or 19%, dropped out: two in Kansas after the first therapy session; and two in New Mexico, one after seven sessions and one no show after enrollment.

Table 1. Baseline recruitment by study site and participant demographics

One of the recruited participants was in the early stages of the ACT sessions at the time of this study, so Table 2 shows follow-up data for 20 participants who had the time in study to finish ACT sessions. It includes the four dropouts. In Kansas, the 2 dropouts missed 14 sessions, and in New Mexico (NM), 2 dropouts missed 9 sessions. All others completed their sessions. This resulted in an overall ACT completion rate of 86%. The overall PEG collection the rate was 91%; 5 of the remaining non-dropouts in NM did not complete a PEG during their ACT sessions; 8 in North Carolina.

Table 2. ACT intervention and PEG outcome measure frequency of completion

a One recruited Kentucky patient excluded because of insufficient time available to complete therapy sessions.

Table 3 shows the CONSORT extension checklist items evaluated in this study.

Table 3. Challenges, lessons learned, and solutions by CONSORT checklist item

Single IRB

This study was the first project at UNM to use single IRB as a prime site [Reference Cobb17]. The process to obtain approval was challenging, but close communication between the research teams and their IRBs facilitated a successful process. Subsequent modifications were centralized, which facilitated a better process.

Recruitment and Retention

The recruitment flyer stated the goal of decreasing opioid use, something we quickly learned, was a deterrent for those taking chronic prescription opioids. Initially, the upper age limit was 65 years, but we learned there were many older eligible patients and changed inclusion to anyone over the age of 18. We relied on PCP providers for patient referrals, but because of competing demands, this resulted in very slow recruitment, and they suggested we use other clinic staff to help recruit. We did expand recruitment to the therapists who helped increase enrollment.

Intervention Implementation: Training/Support for ACT Therapists

Remote ACT training was challenging, given the amount of time required and topic sensitivity. Videoconference sessions were effective, with positive feedback from therapists. Since the training concluded before any ACT sessions were conducted, therapists suggested relevant session-specific reinforcement occurs prior to respective patient sessions.

Rural areas are often challenged by having limited resources. One clinic chose to use health insurance to fund therapist time, rather than accepting study reimbursement. Upon being charged a co-pay, one patient withdrew. After 6 months of negotiation and delayed recruitment, the clinic agreed to revert to study reimbursement.

Intervention Implementation

Some patients had difficulty with transportation and scheduling. Despite this, and dropouts, we had an 86% completion rate (Table 2). Flexibility in the timing of sessions and expanding the time to complete all sessions from 12 to 16 weeks helped retain participants. Some measures activated sensitive issues in patients, i.e., adverse childhood experiences. Expanding therapist training and support sessions during the process of therapy will address this in future studies. Since some therapists did not have availability of an acute mental health unit to refer a suicidal patient, we used the validated PHQ-8 [Reference Shin18] instead of the PHQ-9, which includes a suicidality question.

Baseline Measurement/Data collection

Our multi-site data collection system used Research Electronic Data Capture (REDCap) [Reference Harris19], a browser-based metadata-driven software, to collect and transmit data to a centralized secure server, where an analyzable database was built. To avoid the onerous process of non-UNM study team members obtaining UNM logins and VPN access, data were submitted through a survey link. Therefore, UNM owned the REDCap data, but de-identified site-specific data can be shared.

Collecting numerous surveys remotely by phone proved time consuming and difficult. In-person or phone surveys were administered by research staff when patients had difficulty completing surveys due to health literacy or lack of technology.

Study Administration

Team building fostered trust and engagement, which is important working with a large team across multiple sites and rural practices. We conducted twice monthly videoconferences among site research teams.

Discussion

Lessons learned from this feasibility study provide valuable information to inform a larger, definitive pragmatic trial on ACT as an alternative treatment for rural CNCP patients taking chronic opioids. Recruitment was difficult. Some patients feared joining our study with the stated goal of decreasing opioids. Because the principal aim of a future study will be on testing an alternative treatment for coping with CNCP, not primarily on opioid reduction, we will not mention opioid reduction in future recruitment materials. Instead, because it will remain a secondary goal, we will make it a recruitment criteria and consideration during the behavioral intervention.

Retention showed good feasibility, 86% for completing ACT therapy sessions and 91% for completing PEG pain measures. However, as expected in rural areas, transportation and scheduling visits outside usual primary care were problematic. Possible solutions include conducting telemedicine therapy sessions after at least one in-person visit and reimbursing transportation costs. Some rural participants do not have electronic connectivity, and some had trouble completing the surveys because of health literacy. To improve outcome measurement, we will collect more data in person or by phone when needed, ask questions in more accessible language, and collect the data using more than one session.

Supporting therapists who deliver this intervention presented unexpected barriers. Some patients recruited for “counselling” felt stigmatized, feeling they had a mental health problem. Improved messaging can reduce misconceptions. Training by videoconference worked well, but individualized support during therapy and establishing a training network would help improve the delivery of the intervention. Protecting therapist time and scheduling is a priority because of patient load and competing demands in rural areas. We will consider splitting research funding among multiple therapists so they have a built-in team, can cover one another, and potentially have greater influence on practice leadership.

Study administration in rural multi-site PCPs requires a high level of engagement between researchers and practices [Reference Rhyne and Fagnan20]. Research teams should have ongoing communications with practice leadership, providers, and staff regarding study objectives and progress. In performing practice-based research, compensating practices for their time, resources, space, and interference with workflow helps with practice engagement.

Acknowledgements

We would like to thank everyone who contributed to this project, including each CTSA’s leadership and staff involved in initiating and supporting this project; other study faculty and staff who contributed to study design and/or data collection (Katrina Donahue, MD, MPH, Alicia Brooks, and Neena Khanna); clinics who allowed us to use their space, staff, and patient access (Hidalgo Medical Services, UNC Physicians Network, UNC Family Medicine of Hillsborough); clinic providers and staff (Darrick Nelson, MD, Neal Bowen, PhD, Amanda Frost, MPH, Eric Tucker, EdD, MSW, LCSW); and therapists (Pat Rowan, PsyD, Cherry Hitt, LCAS, LCSW, MSW, Lisa Schweda, Laura Ratzlaff, Robyn Napier).

This work was supported by the University of New Mexico Clinical and Translational Science Center: UL1TR001449 (RR: site PI), University of Kansas Clinical and Translational Science Institute: UL1TR002366 (AG: site PI), University of North Carolina at Chapel Hill, NC Translational and Clinical Sciences Institute: UL1TR002489 (JH: site PI), and University of Kentucky Center for Clinical and Translational Science: UL1TR001998 (ES: site PI).

Disclosures

The authors have no conflicts of interest with any industry or financial agencies within the last 3 years.

References

National Institutes of Health: National Institute on Drug Abuse. Opioid Overdose Crisis [Internet] [cited Nov 4, 2019]. (https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis)Google Scholar
Hadland, SE, et al. Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing. JAMA Internal Medicine 2018. doi: 10.1001/jamainternmed.2018.1999 CrossRefGoogle ScholarPubMed
Chou, R, et al. Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American College of Physicians and the American Pain Society. Annals of Internal Medicine 2007. doi: 10.7326/0003-4819-147-7-200710020-00006 Google ScholarPubMed
Salt, E, et al. A description and comparison of treatments for low back pain in the United States. Orthopedic Nursing 2016. doi: 10.1097/NOR.0000000000000258 CrossRefGoogle ScholarPubMed
Centers for Disease Control and Prevention. Opioid overdose: Drug overdose deaths [Internet] [cited Nov 4, 2019]. (https://www.cdc.gov/drugoverdose/data/statedeaths.html)Google Scholar
Dowell, D, Haegerich, TM, Chou, R. CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016. MMWR Recommendations and Reports 2016; 65(1): 149. doi: 10.15585/mmwr.rr6501e1er CrossRefGoogle ScholarPubMed
Vowles, KE, Sorrell, JT. Life with Chronic Pain: An Acceptance-based Approach [Internet], 2007 [cited Nov 4, 2019]. (https://contextualscience.org/files/CP_Acceptance_Manual_09.2008.pdf)Google Scholar
American Psychological Association - Division 12 Society of Clinical Psychology. Acceptance and Commitment Therapy for Chronic Pain [Internet] [cited Nov 4, 2019]. (https://www.div12.org/treatment/acceptance-and-commitment-therapy-for-chronic-pain/)Google Scholar
Vowles, KE, Wetherell, JL, Sorrell, JT. Targeting acceptance, mindfulness, and values-based action in chronic pain: findings of two preliminary trials of an outpatient group-based intervention. Cognitive and Behavioral Practice 2009. doi: 10.1016/j.cbpra.2008.08.001 Google Scholar
Friedman, DB, et al. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations. American Journal of Health Promotion 2015. doi: 10.4278/ajhp.130514-QUAL-247 CrossRefGoogle ScholarPubMed
Kim, SH, et al. Barriers to clinical trial participation: a comparison of rural and urban communities in South Carolina. Journal of Community Health 2014. doi: 10.1007/s10900-013-9798-2 CrossRefGoogle Scholar
Eldridge, SM, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PLoS One 2016. doi: 10.1371/journal.pone.0150205 Google ScholarPubMed
Schulz, KF, Altman, DG, Moher, D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Annals of Internal Medicine 2010. doi: 10.7326/0003-4819-152-11-201006010-00232 CrossRefGoogle ScholarPubMed
Eldridge, SM, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. Pilot and Feasibility Studies 2016; 2 (1): 64. doi: 10.1186/s40814-016-0105-8 Google ScholarPubMed
Kristunas, CA, et al. The current use of feasibility studies in the assessment of feasibility for stepped-wedge cluster randomised trials: a systematic review. BMC Medical Research Methodology 2019. doi: 10.1186/s12874-019-0658-3 CrossRefGoogle ScholarPubMed
University of New Mexico Clinical and Translational Science Center. Rural Health Research Support Network [Internet] [cited Nov 4, 2019]. (https://hsc.unm.edu/research/ctsc/rhrsn/index.html)Google Scholar
Cobb, N, et al. The SMART IRB platform: a national resource for IRB review for multisite studies. Journal of Clinical Translational Science 2019. doi: 10.1017/cts.2019.394 CrossRefGoogle ScholarPubMed
Shin, C, et al. Comparison of the usefulness of the PHQ-8 and PHQ-9 for screening for major depressive disorder: analysis of psychiatric outpatient data. Psychiatry Investigation 2019. doi: 10.30773/pi.2019.02.01 CrossRefGoogle ScholarPubMed
Harris, PA, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 2009; 42 (2): 377381. doi: 10.1016/j.jbi.2008.08.010 CrossRefGoogle ScholarPubMed
Rhyne, RL, Fagnan, LJ. Practice-based research network (PBRN) engagement: 20+ years and counting. Journal of the American Board of Family Medicine 2018. doi: 10.3122/jabfm.2018.06.180274 CrossRefGoogle Scholar
Figure 0

Table 1. Baseline recruitment by study site and participant demographics

Figure 1

Table 2. ACT intervention and PEG outcome measure frequency of completion

Figure 2

Table 3. Challenges, lessons learned, and solutions by CONSORT checklist item